In a decisive move to safeguard patient health, the West Bengal government has prohibited the use of ten intravenous (IV) fluids across all state-run hospitals. This action follows the tragic death of a young mother and critical illness of several others at Midnapore Medical College and Hospital (MMCH), allegedly linked to the administration of contaminated IV fluids.

Incident Overview

a 30-year-old woman succumbed post-childbirth at MMCH, with four other new mothers reported in critical condition. Preliminary investigations suggest that the administration of Ringer Lactate IV solution, suspected to be contaminated, may have contributed to these adverse outcomes.

Immediate Government Response

In response to these events, the Directorate of Health Services issued an immediate directive to all public hospitals to cease the use of the following IV fluids:

1. Ringer Lactate
2. Ringer Solution
3. Dextrose Injection
4. Sodium Chloride Injection
5. Dextrose and Sodium Chloride Injection
6. Mannitol Injection
7. Potassium Chloride Injection
8. Calcium Gluconate Injection
9. Amino Acid Injection
10. Fat Emulsion Injection

These products, manufactured by Paschim Banga Pharmaceuticals, a unit of Farista Vanijya Limited based in Chopra, North Dinajpur, have been suspended pending a comprehensive quality assessment.

Background and Preceding Actions

Prior to this incident, concerns regarding the quality of IV fluids from the same manufacturer had been raised. In November-December 2024, maternal deaths in Ballari, Karnataka, were linked to substandard Ringer Lactate solutions from this company. Subsequent investigations revealed that 22 batches failed sterility, endotoxin, and particulate matter tests, leading the Karnataka government to blacklist the manufacturer. The findings were communicated to West Bengal authorities, who initially banned the Ringer Lactate IV fluid on December 10, 2024.

Current Investigation and Measures

A Special Investigation Team, led by Ashis Biswas, Officer on Special Duty for Medical Examination, has been deployed to MMCH to conduct an in-depth inquiry into the recent incidents. Preliminary findings indicate that, despite the December 10 ban, the prohibited IV fluids continued to be administered, suggesting lapses in communication and enforcement. The investigation aims to determine the extent of these lapses and ensure accountability.

Statewide Implications

Reports indicate that several government health facilities, including some in Kolkata, were administering the banned fluids, highlighting systemic issues in policy implementation. The government has now mandated all hospitals and medical colleges to immediately halt the use of the specified IV fluids and ensure their removal from inventories.

Commitment to Patient Safety

The West Bengal government reaffirms its commitment to patient safety and the provision of high-quality healthcare. A comprehensive review of procurement processes, quality control measures, and communication protocols is underway to prevent such incidents in the future. Healthcare professionals and administrative staff are urged to adhere strictly to updated guidelines and ensure vigilant monitoring of medical supplies.

Public Advisory

Patients and their families are advised to remain informed and report any concerns regarding medical treatments to hospital authorities promptly. The government is dedicated to maintaining transparency and will provide regular updates as the investigation progresses.